Fareed Ahmad
Doha, DA, Qatar
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 65 publications
Pristimerin drives ROS-dependent apoptosis in cutaneous T-cell lymphoma via inhibition of the AKT-SKP2 axis.
Journal: Toxicology and applied pharmacology
Published: February 05, 2026
Pristimerin drives ROS-dependent apoptosis in cutaneous T-cell lymphoma via inhibition of the AKT-SKP2 axis.
Journal: Toxicology and applied pharmacology
Published: February 05, 2026
Longitudinal Plasma Proteome of Pfizer/BNT162b2 Pre- and Postbooster Vaccinated Healthy Individuals Reveals Distinct Protein Profiles upon SARS-CoV-2 Spike Protein Stimulation.
Journal: Journal of proteome research
Published: February 03, 2026
Pristimerin Suppresses Janus Kinase/Signal Transducers and Activators of Transcription Oncogenic Signaling To Drive Mitochondrial and Caspase-Dependent Apoptosis in Multiple Myeloma.
Journal: ACS pharmacology & translational science
Published: December 29, 2025
Adaptive control of DC-DC power converter: design and experimental investigation with constant power load.
Journal: Scientific reports
Published: August 10, 2025
Ketamine and dodecyl maltoside synergy as a potential topical therapeutic approach for melanoma.
Journal: Scientific reports
Published: July 11, 2025
Selective induction of apoptosis in T-cell acute lymphoblastic leukemia by pristimerin through dual PI3K/AKT pathway inhibition and ROS generation.
Journal: European journal of pharmacology
Published: June 25, 2025
Cathelicidin LL-37-Induced Transcriptome of Human Keratinocyte Identifies Chemokine CXCL10 Link to T-Cell-Mediated Rosacea Pathogenesis through Jak1/STAT1 Pathway.
Journal: The Journal of investigative dermatology
Published: June 11, 2025
Three cases of chronic photodermatitis successfully treated with upadacitinib.
Journal: Skin health and disease
Published: May 29, 2025
Last Updated: 09/26/2026